Sharon Bio-Medicine is currently trading at Rs. 435.20, up by 27.40 points or 6.72% from its previous closing of Rs. 407.80 on the BSE.
The scrip opened at Rs. 426.85 and has touched a high and low of Rs. 441.50 and Rs. 426.85 respectively. So far 45005 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 441.50 on 07-Jan-2014 and a 52 week low of Rs. 272.70 on 20-Nov-2013.
Last one week high and low of the scrip stood at Rs. 441.50 and Rs. 369.90 respectively. The current market cap of the company is Rs. 462.50 crore.
The promoters holding in the company stood at 60.27% while Non-Institutions held 39.73% stake in the company.
Sharon Bio-Medicine is planning to discuss the sub-division of equity shares and issuance of bonus equity shares. In this regard, the meeting of the board of directors of the company will be held on January 14, 2014.
Sharon Bio-Medicine’s Toxicology Laboratories is an independent cost centre and is approved by Department of Science & Technology, Government of India. Government of India has approved Good Laboratory Certificate to SA-FORD which is valid as per OECD Countries - GLP studies.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |